Ledger.Open graph →
SEC Form D · filed November 14, 2014

ORAMED PHARMACEUTICALS INC

Offering
$5.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
JERUSALEM, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Michael Berelowitz · New York, NYDirectorGerald M. Ostrov · Long Branch, NJDirectorConor Walsh · Grand Cayman, Cayman IslandsDirectorMiriam Kidron · Jerusalem, L3Exec · DirectorYifat H. Zommer · Jerusalem, L3ExecLeonard Sank · Cape Town, T3DirectorHarold Jacob · Jerusalem, L3DirectorNadav Kidron · Jerusalem, L3Exec · DirectorJoshua H. Hexter · Jerusalem, L3ExecGlen Macmullin · Grand Cayman, Cayman IslandsDirectorMiriam Kidron · Jerusalem, L3Exec · DirectorYifat H. Zommer · Jerusalem, L3ExecLeonard Sank · Cape Town, T3DirectorHarold Jacob · Jerusalem, L3DirectorNadav Kidron · Jerusalem, L3Exec · DirectorJoshua H. Hexter · Jerusalem, L3ExecGerald M. Ostrov · Long Branch, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗